Effect of honey consumption on type 2 diabetes
Not Applicable
- Conditions
- diabetes.Non-insulin-dependent diabetes mellitusE10, E11,
- Registration Number
- IRCT2015052222364N1
- Lead Sponsor
- Vice Chancellor for research of Shiraz University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
type II diabetic patient with a fasting blood sugar less than 200 milligrams per deciliter ; free of a history or presence of malignancy, acute and emergency states, a history of major operations, a drug history of Immunomodulators, cytotoxic or immunosuppressive agents, free of pregnancy or lactation if female; and not using insulin for diabetes control.
Exclusion criteria: Participants will exclude in the case of any kind of acute diseases, hospitalization or meet the criteria mentioned in Inclusion criteria.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Pars Azmun Kit.;Insulin level. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Immunoradiometric Assay.;Serum malondialdehyde. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Spectrophotometry method.;Serum total antioxidant capacity. Timepoint: Baseline, 8 weeks after baseline, the end of the washout period, 8 weeks after the start of the second period. Method of measurement: Ferric reducing ability of plasma method (FRAP method).
- Secondary Outcome Measures
Name Time Method